Abbott Labs
For individuals with diabetes and their caregivers requiring real-time glucose data and trend analysis.
Libre by Abbott
Snapshot
Who is Abbott Labs?
Providing digital health tools for continuous glucose monitoring. Enabling patients to track glucose trends via smartphone integration.
Target audience
Portfolio
Free 82Last updated
Libre by Abbott
v1.2.1
9mo ago
Publisher DNA
What defines Abbott Labs?
Publisher DNA
Primary focus
Medical device companion apps for glucose monitoring
Scale
indie
Target audience
Individuals with diabetes and their caregivers requiring real-time glucose data and trend analysis.
Signature Patterns
- •Strictly medical utility focused on glucose monitoring and trend reporting.
- •Monetization model relies on hardware sensor sales rather than in-app purchases.
- •Integration with proprietary medical hardware is a mandatory requirement for app functionality.
- •Features prioritize data logging, trend analysis, and glucose level alerts.
Portfolio momentum
Released 4 updates across 3 apps in the last 6 months, maintaining a consistent focus on their core medical monitoring suite.
Portfolio
What does Abbott Labs ship?
Apps
82 apps analysed
Analysis in progress
Analysis in progress
Analysis in progress
Analysis in progress
Analysis in progress
Single-market publisher, every app ships only to United States.
Based on 14 of 82 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States14 / 14
Core markets (14/14 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
1
Neutral / mixed
1
Negative apps
30/100
Avg sentiment score
Unlock the app dragging this portfolio down.
Access the full report for freeRivals
Who does Abbott Labs compete with?
The rivals identified
Nemeses(2)
Both apps target the same diabetes management market by providing glucose pattern analysis and clinical data sharing tools for healthcare providers.
LibreLinkUp functions as the mandatory remote monitoring companion for the same proprietary sensor hardware used by Libre by Abbott, creating a shared user base across patients and their caregivers.
Contenders(8)
Both apps serve the same diabetes management audience and require CGM integration, creating a direct overlap in the patient's daily health-management workflow.
Acts as a platform-agnostic logging alternative for users frustrated by connectivity issues in the source app.
Both apps utilize Abbott's continuous glucose monitoring biosensor hardware to provide real-time metabolic data, creating a direct overlap in sensor-dependent user acquisition.
GlucoWatch competes by providing a dedicated Apple Watch interface for Libre sensor data, addressing the user demand for discreet, wrist-based monitoring that the official app lacks.
Both apps target diabetes management, with Glucose Monitor serving as a manual logging alternative to the automated sensor-based tracking provided by Libre by Abbott.
The leading hardware-agnostic aggregator that positions itself as the 'universal' dashboard for clinical data sharing.
A full-stack health platform that combines hardware, software, and human coaching into a single subscription model.
A high-scale rival focusing on the Blood Glucose Meter (BGM) ecosystem with a massive established user base.
Same space(16)
Functions as a multi-device aggregator that addresses cross-platform synchronization needs for patients and caregivers.
Offers visual analytics for lifestyle metrics that supplement raw glucose data from hardware sensors.
Targets the same management market but relies on manual entry, creating a high-friction experience compared to sensor-based streams.
Provides a legacy tracking alternative that currently suffers from stability issues, driving churn among long-term users.
Operates in the adjacent fertility tracking space, sharing only the broad medical category.
Provides a management tool for diabetes and prediabetes that includes meal guidance and weight tracking.
Focuses on the nutritional aspect of management, complementing the glucose data provided by the source app.
Serves as a specialized companion for patients on specific medication regimens rather than general glucose monitoring.
Competes for clinical data management by offering partner-sharing features that embed the app into the patient-provider care loop.
A personality-driven overlay for CGM data designed to reduce 'diabetes burnout' through humor.
Provides a basic manual logging alternative for users who do not require advanced hardware integration.
Provides specialized pharmacokinetic modeling for medication concentration, serving users with complex dosing needs.
Targets families needing coordinated real-time tracking, offering a less clinical interface than the source app.
Appeals to users prioritizing data privacy and offline access over cloud-connected features.
Focuses on diet and weight management components, serving as a secondary tool for nutrition tracking.
A power-user tool that provides advanced visualization and cross-device syncing for CGM data.
New entrants(1)
An AI-first companion that solves the 'carb counting' pain point which the target app leaves to manual entry.
The Analyst's Read
The bottom line on Abbott Labs
Bottom line
Abbott Labs maintains a highly specialized, hardware-dependent portfolio that serves a critical medical need. Their market position is secure due to hardware integration, though technical stability remains a significant risk factor for their user base.
Frequently asked questions
How many apps does Abbott Labs publish?
What kind of apps does Abbott Labs make?
What is Abbott Labs's top app?
In how many countries are Abbott Labs's apps available?
What fed this analysis
- Apps analyzed:
- 3
- With full intel:
- 1
- With overview:
- 3
- Website scraped:
- yes
- Social presence:
- no